Document:

EXHIBIT 10.1

 

ACQUISITION AGREEMENT

 

This acquisition agreement
(the “Acquisition Agreement”) is entered into as of the 10th day of January 2017 and is effective
as of the 2nd day of January, 2017 (the “Effective Date”),

 

BY AND BETWEEN 

 

		(1)	Rosellini Scientific, LLC, a limited liability company formed under the laws of the State
of Texas, United States of America, having its registered office at 2820 Lynn Dell Tool, Dallas, Texas 75143, United States of
America, registered with the Texas Secretary of State, Division of Corporations under number 46.0827294, represented for the execution
of the present agreement by the undersigned person(s) being duly authorized and fully empowered for that purpose (the “Grantor”);
and

 

		(2)	Nexeon Medsystems Europe, S.à r.l., a Luxembourg private limited
liability company (société à responsabilité limitée), having its registered office at
33, rue du Puits Romain, L-8070 Bertrange, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies register
under number B 210009, represented for the execution of the present agreement by the undersigned person(s) being duly authorized
and fully empowered for that purpose (the “Grantee”),

 

AND IN THE PRESENCE OF

 

Nexeon Medsystems
Belgium S.p.r.l., a company incorporated under the laws of Belgium, having its registered office at Rue du Bois St-Jean 15/1
4102 Seraing, Belgium, registered with the Belgian Companies Register (BCE) under number 0525.673.682, represented for the execution
of the present agreement by the undersigned person(s) being duly authorized and fully empowered for that purpose (“BelCo”).

 

The Grantor and the Grantee
are hereafter referred to collectively as the “Parties” or individually referred to as a “Party”.

 

PREAMBLE

 

WHEREAS the Grantor
and the Grantee, which is a wholly-owned subsidiary of Nexeon Medsystems, Inc., a Nevada corporation, are part of the Nexeon group
of companies (the “Group”) that is currently being restructured in order to achieve a more efficient and cost
effective Group structure (the “Restructuring”);

 

    	1

    	 

    

 

WHEREAS the Grantor
is the sole shareholder owning 107,154 (one hundred seven thousand one hundred fifty-four) shares of Belco having a par value of
EUR 1.- (one euro) each in the share capital of BelCo (the “Shares”);

 

WHEREAS the Grantor
wishes to grant to the Grantee the exclusive and irrevocable right to purchase the Shares upon the terms and conditions set forth
herein (the “Right to Purchase”), and the Grantee desires to accept the Right to Purchase in consideration for
the payment of an amount of USD 1,000 (one thousand United States dollars) (the “Acquisition Price”);

 

WHEREAS in view of
the Restructuring the Grantee shall have the right to exercise the Right to Purchase at any time during the period commencing as
of the date hereof and terminating on 31 December 2017 (the “Acquisition Period”); and

 

WHEREAS, in the event
the Grantee timely exercises the Right to Purchase, this Acquisition Agreement shall be automatically deemed converted into and
considered a share transfer agreement (the “Share Transfer Agreement”) for the purchase, by the Grantee from
the Grantor, of the Shares, on the terms and conditions herein set forth herein (the “Share Transfer”).

 

NOW THEREFORE, 

 

IN CONSIDERATION of
the mutual agreements herein set forth, and other valuable consideration, receipt of which is hereby acknowledged, the Parties
hereby agree as follows:

 

ARTICLE I

GRANT OF RIGHT TO PURCHASE

 

		1.	In consideration of the payment by Grantee to Grantor of the Acquisition Price, the Grantor hereby
grants to the Grantee, and the Grantee hereby accepts, the exclusive and irrevocable Right to Purchase pursuant to the terms, covenants
and conditions set forth herein. By signing the present Acquisition Agreement the Grantor hereby acknowledges having received the
Acquisition Price.

 

ARTICLE II

TERM AND MANNER OF EXERCISE OF RIGHT TO PURCHASE

 

		2.1.	The Right to Purchase shall be exercisable by the Grantee at any time during the Acquisition Period
upon a two (2) day prior written notice by Grantee to Grantor in accordance with the present Acquisition Agreement and prior to
the expiration of the Acquisition Period. Such notice shall be made in writing.

 

    	2

    	 

    

 

		2.2.	If the Grantee elects to exercise the Right to Purchase, the consummation and closing of the Share
Transfer (the “Closing”) shall take place at 10:00 a.m. (CET), on a date to be specified by the
Parties, which shall not be earlier than two (2) business days (i.e. a day during which banks in Luxembourg are open for general
business purposes) following the exercise of such Right to Purchase (the “Closing Date”) at the offices of Grantee,
unless another date, place or time is agreed to in writing by the Parties hereto.

 

		2.3	If the Grantee elects not to exercise the Right to Purchase on or before the last date of the Acquisition
Period, the Right to Purchase and this Acquisition Agreement shall be deemed cancelled and terminated and thus be null and void
and of no further force and effect. If the Grantee timely and validly exercises the Right to Purchase, this Acquisition Agreement
shall automatically become and be deemed a Share Transfer Agreement on the terms and conditions herein set forth. Parties hereby
irrevocably undertake, in case of Grantee’s timely exercise of the Right to Purchase, to prepare and sign all such documents
and to do whatever is necessary under Belgian law, and any other applicable laws, in order to complete and implement the Share
Transfer effective as of the Closing Date.

 

ARTICLE III

ACQUISITION PRICE

 

		3.1.	In consideration for the Share Transfer, and any and all rights and benefits granted thereunder
to the Grantee during the Acquisition Period, the Grantee shall pay to the Grantor by wire transfer of immediately available funds
the Acquisition Price; provided, however, that the Grantee will be entitled to deduct and withhold or cause the Grantor
to deduct and withhold any withholding taxes or other amounts required under the applicable laws to be deducted and withheld. To
the extent that any such amounts are so deducted or withheld, such amounts will be treated for all purposes of this Acquisition
Agreement as having been paid to the person or entity in respect of which such deduction and withholding was made.

 

		3.2.	In the event the Grantee elects to exercise the Right to Purchase, the Acquisition Price will equal
to and shall be considered the purchase price of the Shares (the “Purchase Price”) and shall be deemed to have
been satisfied by Grantee to Grantor as of the date of this Acquisition Agreement.

 

    	3

    	 

    

 

ARTICLE IV

TERMS OF THE SHARES TRANSFER

 

		4.1.	In the event the Grantee elects to exercise the Right to Purchase, the Grantee shall purchase and
acquire from Grantor, and the Grantor shall sell, transfer and convey to Grantee the Shares on the terms set forth in the present
section.

 

		4.2.	The Grantor shall sell, transfer and convey the Shares to Grantee with all its title, rights and
interest in and to the Shares, including but not limited to any rights to receive payment(s) thereunder, in exchange for the Purchase
Price, all this under the terms and conditions of this Acquisition Agreement.

 

		4.3.	The Grantee shall purchase and acquire the Shares free and clear from any liens and encumbrances,
whether known or unknown to the Grantor, together with all accrued benefits and rights attached thereto, in exchange for the Purchase
Price, all this under the terms and conditions of this Acquisition Agreement.

 

		4.4.	The Grantor and the Grantee agree to and confirm the Purchase Price to be considered paid per the
terms and conditions as set forth herein.

 

		4.5.	The Grantor shall execute and/or deliver all necessary documents and/or instruments of the transfer
of the Shares and take all necessary steps and actions in order to make effective the Share Transfer to the Grantee on the Closing
Date.

 

		4.6.	In this respect, the Grantor unconditionally undertakes to cause the Grantee’s ownership
of the Shares to be supported and evidenced by executing the relevant documentation and perform any necessary filings and registrations,
as the case may be.

 

		4.7.	The consideration to be paid by the Grantee to the Grantor for the sale, transfer and conveyance
of the Shares from Grantor to Grantee shall be equal to the amount of the Purchase Price.

 

		4.8	Upon the execution hereof Grantor shall cause to commence the performance of an audit of Belco
for the financial years ending December 31, 2015 and ending December 31, 2016, respectively, and to be fully and unconditionally
completed by April 15, 2017 at the latest. The Grantor shall be solely responsible and liable for any and all fees, costs and expenses
associated with such audit. The audit shall be conducted in compliance with United States GAAP and PCAOB Standards along with any
other requirements in conjunction with the financial reporting regulations as issued and applied by the U.S. Securities and Exchange
Commission.

 

    	4

    	 

    

 

ARTICLE V

TITLE

 

		5.	The Grantor agrees that it will not create or cause to create any encumbrance, lien or other matter
which would adversely affect or encumber title to the Shares during the term of this Acquisition Agreement and Acquisition Period
without first securing the written consent of the Grantee.

 

ARTICLE VI 

 

REPRESENTATIONS AND WARRANTIES OF THE GRANTOR

 

		6.1.	As an inducement to the Grantee to enter into and perform this Acquisition Agreement, the Grantor
hereby represents and warrants to the Grantee as follows:

 

(i)           
it is (a) duly organized, validly existing and in good standing under the laws of the State of Texas, and (b) is duly qualified
to do business and in good standing in each jurisdiction it is qualified;

(ii)          
it has legal right and full power and authority to grant the Right to Purchase as provided for herein and, should the Grantee
decide to exercise the Right to Purchase, to agree to and with the Share Transfer;

(iii)        
the execution, delivery and performance of the Right to Purchase by the Grantor and the consummation of the transactions
contemplated hereby has been duly authorized by all corporate actions required on the part of the Grantor, and does not, and will
not, violate any of its constitutional documents or any statutes, laws, orders, regulations, agreements, contracts or similar commitments
to which the Grantor or any of its properties is subject;

(iv)         
the Shares are in registered form and fully paid and non-assessable;

(v)          
the Shares are legally and freely available and unencumbered for the creation of the Right to Purchase in favour of the
Grantee and, should the Grantee decide to exercise the Right to Purchase, for the Share Transfer, with all rights and benefits
attached thereto, including but not limited to the rights to receive payments thereunder;

(vi)         
the Shares subject to the Right to Purchase are owned by the Grantor as the sole legal and beneficial owner thereof, are
not subject to any pledge, lien, claim or other encumbrance of any kind, and are not subject to any restriction on transfer or
assignment or by any statutes, laws, orders or regulations or any other condition that (a) will or may prevent or impede the creation
of the Right to Purchase in favour of the Grantee, or (b) has not been fully disclosed to the Grantee in writing by the Grantor;

 

    	5

    	 

    

 

(vii)       
any and all necessary waivers, authorisations, consents and all necessary formalities, as the case may be, have been undertaken
and/or obtained in order to allow the Grantor to grant the Right to Purchase; and

(viii)     
any and all further formalities, as the case may be, shall be duly carried out by the Grantor in order to duly formalise
the Right to Purchase and to render it effective anywhere and towards any third party to the extent this would be required or advisable.

 

ARTICLE VII 

 

REPRESENTATIONS AND WARRANTIES
OF THE GRANTEE

 

		7.1.	As an inducement to the Grantor to enter into and perform this Acquisition Agreement, the Grantee
hereby represents, and warrants to the Grantor that:

 

(i)            
it is (a) duly organized, validly existing and in good standing under the laws of the Grand Duchy of Luxembourg, and (b)
is duly qualified to do business and in good standing in each jurisdiction in which it is qualified;

(ii)          
the execution, delivery and performance of this Acquisition Agreement by the Grantee and the consummation of the transactions
contemplated hereby has been duly authorized by all corporate actions required on the part of the Grantee, as the case may be,
and will not violate its articles of association, statutes, laws, orders, regulations, agreements, contracts and similar commitments
to which the Grantee or any of its properties is subject; and

(iii)        
it has legal right and full power and authority to execute and deliver, and to exercise its rights and perform its obligations
under this Acquisition Agreement;

 

ARTICLE VIII

COMMISSIONS

 

		8.	The Grantor and the Grantee each hereby represents and warrants to each other that neither of them
has dealt with any broker, finder, agent or any other person who might be entitled to a fee in connection with the purchase and
sale of the Shares and that no fee or commission is due to any broker, finder, agent or other person in connection with this Acquisition
Agreement or the sale and purchase of the Shares contemplated thereby. The Grantor and the Grantee each hereby indemnify the other
and agree to hold the other harmless from and against any and all claims, demands, liabilities, losses, judgments, costs and expenses
(including, without limitation, reasonable attorneys’ fees) arising directly or indirectly out of any claim for a fee or
commission due to any broker, finder, agent or any other person arising out of facts which contravene the warranties herein stated.

 

    	6

    	 

    

 

ARTICLE IX

ASSIGNMENT AND SURVIVAL

 

		9.1	Neither the Grantee nor the Grantor may assign this Acquisition Agreement or any of their rights
hereunder for any purpose whatsoever without the prior written consent of the other party (which consent shall not be unreasonably
withheld by either party) and any purported assignment without such consent shall be absolutely void and of no force and effect.

 

		9.2	The respective representations and warranties of each of the contained herein or in any certificate
or schedule delivered pursuant hereto shall expire with, and be terminated and extinguished on the Closing Date, and thereafter
neither the Grantor nor the Grantee, nor any of their respective affiliates and subsidiaries, shall be under any liability whatsoever
with respect to any such representation or warranty.

 

ARTICLE X

MISCELLANEOUS

 

		10.1.	Entire Agreement. This Acquisition Agreement (including any exhibits and schedules
hereto) contains the entire understanding of the Parties hereto with respect to the subject matter hereof, and no prior or contemporaneous
written or oral agreement or understanding pertaining to any such matter shall be effective for any purpose. Time is of the essence
with regard to this Acquisition Agreement.

 

		10.2.	Attorneys’ Fees. Should any action be brought arising out of this Acquisition
Agreement, including without limitation any action for declaratory or injunctive relief, the prevailing party shall be entitled
to payment, reimbursement, settlement or compensation of reasonable attorneys’ fees and costs and expenses incurred in connection
with any court case or proceeding under the provision of the present Acquisition Agreement or the relevant applicable law as described
in the present Acquisition Agreement, and any judgment or decree rendered in any such actions or proceedings shall include an award
thereof.

 

    	7

    	 

    

 

		10.3.	Binding Effect. The provisions of this Acquisition Agreement shall inure to the benefit
of and be binding upon the Grantor and the Grantee and their respective successors and permitted assigns each of which such successors
and permitted assigns will be deemed to be a Party hereto for all purposes hereof. Except as expressly provided herein, this Acquisition
Agreement is for the sole benefit of the Parties and their permitted successors and assignees and nothing herein expressed or implied
will give or be construed to give any person or entity, other than the Parties and such successors and assignees, any legal or
equitable rights hereunder.

 

		10.4.	No Waiver. No waiver of any of the provisions of this Acquisition Agreement shall
be deemed, or shall constitute, a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing
waiver. No waiver shall be binding unless executed in writing by the party making the waiver. No waiver by any Party of any breach
or violation or, default under or inaccuracy in any representation, warranty or covenant hereunder, whether intentional or not,
will be deemed to extend to any prior or subsequent breach, violation, default of, or inaccuracy in, any such representation, warranty
or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence. No delay or
omission on the part of any Party in exercising any right, power or remedy under this Acquisition Agreement will operate as a waiver
thereof.

 

		10.5.	Further Acts. Each party shall, at the request of the other, execute, acknowledge
(if appropriate) and deliver whatever additional documents, and do such other acts, as may be reasonably required in order to accomplish
the intent and purposes of this Acquisition Agreement.

 

		10.6.	Counterparts. This Acquisition Agreement may be executed in counterparts, each of
which so executed shall be deemed to be an original, and such counterparts shall together constitute but one and the same agreement.
This Acquisition Agreement may be executed by facsimile or pdf. signature, which in each such case shall constitute an original
for all purposes.

 

		10.7.	Amendments. This Acquisition Agreement may not be changed or modified except by an
instrument in writing executed by the party asserted to be bound thereby.

 

		10.8.	Notices. All notices, requests, demands, claims and other communications required
or permitted to be delivered, given or otherwise provided under this Acquisition Agreement must be in writing and must be delivered,
given or otherwise provided:

(a)       by
hand (in which case, it will be effective upon delivery);

(b)       by
facsimile or electronic mail (in which case, it will be effective upon receipt of confirmation of good transmission); or

    	8

    	 

    

 

(c)       by
overnight delivery by a nationally recognized courier service (in which case, it will be effective on the business day after being
deposited with such courier service);

in each case, to the address
set forth herein above.

 

Each of the Parties to this Acquisition
Agreement may specify different address by giving notice in accordance with section 10.8 to each of the other Parties hereto.

 

		10.9.	Headings. Any headings in this Acquisition Agreement are solely for the convenience
of the parties and are not part of this Agreement.

 

		10.10.	Governing Law and Jurisdiction. This Acquisition Agreement and the transaction(s)
herein contemplated shall be construed in accordance with and governed by the laws of the Grand Duchy of Luxembourg. In case of
dispute between the Parties the courts of and in Luxembourg will have jurisdiction to settle such dispute unless Parties, by common
consent, desire to chose another court.

 

[the remainder of this
page is intentionally left blank and signature page is to follow]

 

    	9

    	 

    

 

IN WITNESS WHEREOF,
the Grantor and the Grantee have executed this Acquisition Agreement on the day and year first above written in two originals,
each Party acknowledging having received its own original.

 

	Rosellini Scientific, LLC,
	 	 	 
	 	 	 
	Signature:	/s/ William Rosellini	 
	Name:	William Rosellini	 
	Title:	Manager	 

 

 

 

	Nexeon Medsystems Europe, S.à r.l., 
	 	 	 
	 	 	 
	Signature:	/s/ William Rosellini	 
	Name:	William Rosellini	 
	Title:	CEO	 

 

 

AND
FOR ACKNOWLEDGMENT PURPOSES:

 

	Nexeon Medsystems Belgium S.p.rl.,
	 	 	 
	 	 	 
	Signature:	/s/ William Rosellini	 
	Name:	William Rosellini	 
	Title:	CEO	 

 

 

    	10EXHIBIT 10.2

 

loan agreement

 

This loan agreement (the “Agreement”)
made as of 10th January 2017 by and between:

 

(i)     
Nexeon Medsystems Europe, S.à r.l., a private limited liability company (société
à responsabilité limitée), having its registered office at 33, rue du Puits Romain, L-8070 Bertrange,
Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies register under number B 210009 (hereinafter called
the “Lender”); and

 

(ii)   
Nexeon Medsystems Belgium S.p.r.l., a company incorporated under the laws of Belgium, having its registered office
at Rue du Bois St-Jean 15/1 4102 Seraing, Belgium, registered with the Belgian Companies Register under number BE 0525.673.682
(hereinafter called the “Borrower”).

 

PREAMBLE

 

WHEREAS pursuant to a certain Acquisition
Agreement dated on or about January 10, 2017 by and between the Lender and Borrower, it is contemplated that the Lender acquires
or shall acquire all of the shares of the Borrower, and any all rights and benefits thereto, including the right to receive payment(s)
thereunder, in order for Borrower to become a part of the Nexeon group of companies (the “Group”) whereby said
Group is currently being restructured in order to achieve a more efficient and cost effective Group structure (hereinafter referred
to as the “Restructuring”);

 

WHEREAS, in order
to facilitate the Restructuring, the Lender hereby wishes to grant a loan to the Borrower, which loan the Borrower hereby wishes
to accept;

 

NOW THEREFORE, for
good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

 

SECTION 1.     DEFINITIONS.

 

Unless the context otherwise
requires, the terms listed below and used in this Agreement shall have the following meanings:

 

“Agreement”
shall mean this Agreement and any amendments, modifications, supplements or extensions hereto;

 

    	1

    	 

    

 

“Business Day”
shall mean any day other than Saturday and/or Sunday or a day on which businesses are officially closed in Luxembourg or Belgium;

“Closing Date”
shall mean the effective date hereof, being 10th January 2017;

“Collateral”
shall mean the collateral as defined in the Security Agreement and all the collateral or similar terms as defined in any other
Collateral Document and, to the extent applicable, any other assets pledged or assigned pursuant to any Collateral Document;

“Collateral Document”
shall mean the Security Agreement and any and all mortgages, collateral assignments, promissory notes, security agreements, pledge
agreements, intellectual property security agreements or other similar agreements or instruments, to the extent applicable, delivered
to the Lender pursuant to this Agreement;

“Default”
shall mean any of the events specified in Section 5 hereof, whether or not any requirement for the giving of notice or the lapse
of time or both or any other condition has been satisfied;

“Event of Default”
shall mean any of the events specified in Section 5 hereof, provided that any requirement for the giving of notice or the lapse
of time or both has been satisfied;

“Loan”
shall mean the loan made hereunder pursuant to Section 2.1 hereof;

“Maturity Date”
shall mean the first Business Day falling one (1) year from the date hereof, or the Notification Date, or as such date is extended
from time to time pursuant to Section 2.2 hereof;

“Notification”
shall mean the written notice pursuant to Section 2.3 hereof;

“Notification Date”
shall mean the day on which the Notification pursuant to Section 2.3 has been duly made;

“Permitted Liens”
shall mean the permitted liens as defined in the Security Agreement;

“Principal Loan
Amount” shall mean the principal amount pursuant to Section 2.1 hereof;

“Security Agreement”
shall mean the security agreement dated on or about January 10, 2017, by and between the Lender and the Borrower; and

“Taxes”
shall mean the taxes specified in Section 2.4 hereof.

 

Section
2.     AMOUNT AND TERM OF LOAN

 

Section 2.1     Principal
Amount; Disbursement. Subject to the terms and conditions of this Agreement, the Lender agrees to make a loan to the Borrower
in the aggregate principal amount of EUR 1,000,000 (One Million Euros) (the “Loan”).

 

Section 2.2     Maturity;
Term. The Loan shall mature on the Maturity Date; provided, however, that the Maturity Date shall be extended
and the term of this Agreement automatically renewed for successive thirty (30) day periods unless the Borrower notifies the Lender
within ten (10) days of the then upcoming Maturity Date that it intends to repay the full amount or then outstanding amount of
the Loan prior to the then upcoming Maturity Date.

 

    	2

    	 

    

 

Section 2.3      Interest; Repayments.
The outstanding and unpaid principal of the Loan shall bear interest at the rate of 5% (Five Percent) per annum on a 365 day year
basis and the actual number of days elapsed. Interest shall be payable in the manner specified in Section 2.4 below. The Borrower
may apply any amount it then owes or may come to owe to the Lender for the repayment of the Loan. The Borrower may repay, either
partially or entirely, the Loan and/or accrued interest thereon at any time prior to the Maturity Date without penalty, upon giving
at least two (2) Business Days’ prior written notice to the Lender. Borrower and Lender may also agree to settle the Loan
through the inter-company account netting procedure.

 

Section 2.4      Payment of Accrued
Interest. Accrued interest on the unpaid principal amount of the Loan shall be payable on the Maturity Date. Accrued interest
on any partial repayment of the Loan shall be payable on the earlier of the date of repayment or first Business Day of the month
following partial repayment. Any such payment is to be effected by Borrower paying to Lender’s bank account in immediately
available funds the amount of the partial repayment and accrued interest; provided, however, that upon any repayment of the Loan
in full, accrued interest thereon shall be payable at that time.

 

The Borrower and the Lender may agree to capitalize
the total interest accrued at maturity. The Borrower and the Lender may further agree to settle the applicable interest through
the inter-company account netting procedure.

 

Section 2.5     Taxes.

(a)        If
any taxes, impositions or similar charges (the “Taxes”) shall be required by law to be deducted from or in respect
of any sum payable hereunder to the Lender, (i) the Borrower shall make such deductions, and (ii) the Borrower shall pay the full
amount deducted to the relevant taxing authority in accordance with applicable law. The Borrower shall hold the Lender harmless
from any liability with respect to the delay or failure by the Borrower to pay any Taxes.

(b)       Within
thirty (30) days after the date of any payment of Taxes withheld by the Borrower in respect of any payment to the Lender, the Borrower
will furnish to the Lender the original or a certified copy of a receipt acceptable to the Lender evidencing full and unconditional
payment thereof.

 

    	3

    	 

    

 

SECTION 3.     CONDITIONS TO BORROWING

 

The borrowing pursuant to
Section 2.1 hereof shall be subject to the fulfillment of the following conditions precedent:

 

(a)       Representations
and Warranties; No Default. Any representations and warranties required to be made by the Borrower in connection with this
Agreement shall be true and correct as of the Closing Date; the Borrower shall have performed all obligations and agreements and
complied with all covenants and conditions required to be performed or complied with by it prior to or on the Closing Date; and
no Event of Default shall have occurred and be continuing.

(b)       Collateral
Documents. The Security Agreement creates in favor of the Lender, as secured party, a legal, valid and enforceable security
interest in the Collateral (as defined in the Security Agreement), the enforceability of which is subject to applicable bankruptcy,
insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles
of equity, regardless of whether considered in a proceeding in equity or law. When the Security Agreement (or a short form thereof)
in proper form is filed in or with the applicable patent office, if any, the Lender shall have a fully perfected lien on, and security
interest in, all right, title and interest of the applicable loan party in the intellectual property Collateral (as defined in
the Security Agreement) in which a security interest may be perfected by filing, recording, or registering a security agreement
or analogous instrument in the applicable patent office, as applicable, in each case prior and superior in right to any other person
or entity to the extent required, subject to Permitted Liens having priority under applicable laws. Each Collateral Document to
which any loan party is a party creates for the benefit of the Lender, as secured party, the legal, valid and enforceable first
priority security interest which such Collateral Document purports to create (subject to Permitted Liens). Without limiting the
foregoing, and to the extent applicable, each Collateral Document governed by Luxembourg law creates in favor of the Lender, as
secured party, an effective first priority pledge over the collateral described therein to be subject to the pledge (subject by
Permitted Liens), enforceable in accordance with its terms, once perfected in accordance with the terms of such Collateral Document.

(c)       Legal
Matters. All other instruments and legal and corporate proceedings in connection with the transactions contemplated by this
Agreement shall be satisfactory in form and substance to the Lender and its counsel, and counsel to the Lender shall have received
copies of all documents which it may have reasonably required in connection therewith.

(d)       Conflict.
Notwithstanding anything to the contrary herein, in the event that any provision of this Agreement is deemed to conflict with the
Security Agreement or any of the Collateral Documents, the provisions of this Agreement shall control unless the Lender shall otherwise
determine.

 

    	4

    	 

    

 

SECTION 4.     COVENANTS.

 

Existence. Conduct of
Business. The Borrower will, and will cause each of its subsidiaries and affiliates to, do or cause to be done all things necessary
to preserve, renew and keep in full force and effect its legal existence and the rights, licenses, permits, privileges and franchises
material to the conduct of its business; provided that the foregoing shall not prohibit (i) any merger, consolidation, liquidation,
dissolution or stock or asset sale, or (ii) the conversion of a subsidiary (other than the Borrower) into a limited liability company,
a corporation or other organizational form.

 

Payment of Obligations.
The Borrower will, and will cause each of its subsidiaries and affiliates to, pay its obligations, including tax liabilities, that,
if not paid, could result in a material adverse effect before the same shall become delinquent or in default, except where (a)
the validity or amount thereof is being contested in good faith by appropriate proceedings, (b) such party or such subsidiary or
affiliate has set aside on its books adequate reserves with respect thereto in accordance with GAAP and (c) the failure to make
payment pending such contest could not reasonably be expected to result in a material adverse effect.

 

Compliance with laws.
The Borrower will, and will cause each of its subsidiaries and affiliates to, comply with all laws, rules, regulations and orders
of any governmental authority applicable to it or its property, except where the failure to do so, individually or in the aggregate,
could not reasonably be expected to result in a material adverse effect.

 

Notices. The Borrower
hereby covenants that so long as any indebtedness of the Borrower under this Agreement remains outstanding and unpaid, the Borrower
shall, unless otherwise consented to in writing by the Lender, promptly give notice in writing to the Lender of (a) the occurrence
of any Default under this Agreement or any other material agreement of the Borrower, and (b) any litigation, proceeding, investigation
or dispute which may exist or threatening to occur at any time between the Borrower and any third party which might substantially
interfere with the normal business activity of the Borrower or the performance of any obligation under this Agreement.

 

SECTION 5.     EVENTS OF
DEFAULT.

 

Upon the occurrence of any of the following:

 

(a)       failure
by the Borrower to pay the principal of the Loan when due and payable;

 

    	5

    	 

    

 

(b)       if
any representation or warranty made by the Borrower in connection with Section 3(a) hereof or in any certificate, financial or
other statement furnished at any time under or in connection with this Agreement shall prove to have been untrue or misleading
in any material respect when made;

(c)       default
by the Borrower in the observance or performance of any other covenant or agreement contained in this Agreement, and the continuance
of the same for thirty (30) days after written notice of such default is given to the Borrower by the Lender;

(d)       if
the Borrower shall default in the payment of principal amount any obligation for borrowed money or fail to discharge any final
judgment rendered against it having a principal amount in excess of EUR 10,000.- (ten thousand Euros) or the equivalent in any
other currency beyond the relevant grace period, if any, with respect thereto;

(e)       (i)
the Borrower shall commence any case, proceeding or other action (a) under any existing or future law of any jurisdiction, domestic
or foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered
with respect to it, or seeking to adjudicate it bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, liquidation,
dissolution, composition or other relief with respect to it or its debts or (b) seeking appointment of a receiver, trustee, custodian
or other similar official for it for all or any substantial part of its property, or the Borrower shall make a general assignment
for the benefit of its creditors; or (ii) there shall be commenced against the Borrower any case, proceeding or other action of
a nature referred to in clause (i) above or seeking issuance of a warrant of attachment, execution, distraint or similar process
against all or any substantial part of its property, which case, proceeding or other action (x) results in the entry of an order
for relief or (y) remains undismissed, undischarged or unbounded for a period of sixty (60) days; or (iii) the Borrower shall take
any action indicating consent to, approval for, or acquiescence in, or in furtherance of, any of the acts set forth in clause (i)
or (ii) above; or (iv) the Borrower shall generally not, or shall be unable to, pay its debts as they become due or shall admit
in writing its inability to pay its debts; or

(f)       any
material adverse change (as reasonably determined by the Lender) shall have occurred in the financial condition of the Borrower;

 

(X) if such event of default (“Event
of Default”) is an event specified in Section 5(e) above, then the principal amount of the Loan shall be immediately
due and payable without notice or demand; and (Y) if such Event of Default is any other event of default specified above, the Lender
may declare, by written notice to the Borrower, the Loan then outstanding to become forthwith due and payable, whereupon the principal
amount of the Loan shall become immediately due and payable, together with accrued interest thereon and all fees and other obligations
of the Borrower accrued hereunder, without presentment, demand, protest or other notice of any kind, all of which are expressly
waived, anything contained herein to the contrary notwithstanding.

 

    	6

    	 

    

 

SECTION 6.      REMEDIES.

 

		(a)	At any time an Event of Default exists or has occurred and is continuing, the Lender shall have
all rights and remedies provided in this Agreement, all of which rights and remedies may be exercised without notice to or consent
by any loan party, except as such notice or consent is expressly provided for hereunder or required by applicable laws. All rights,
remedies and powers granted to the Lender hereunder, under any of the other Collateral Documents r other applicable laws, are cumulative,
not exclusive and enforceable, in Lender’s discretion, alternatively, successively, or concurrently on anyone or more occasions,
and shall include, without limitation, the right to apply to a court of equity for an injunction to restrain a breach or threatened
breach by any loan party of this Agreement or any of the other Collateral Documents.

 

		(b)	Without limiting the generality of the foregoing, at any time an Event of Default exists or has
occurred and is continuing, the Lender may, at its option, upon notice to the Borrower, accelerate the payment of all obligations
and demand immediate payment thereof to the Lender.

 

SECTION 7.     INDEMNIFICATION.

 

The Borrower agrees to indemnify
the Lender from and against any and all claims, losses and liabilities growing out of or resulting from the occurrence of any Default
of this Agreement, including, but not limited to, the costs for the enforcement hereof. The Borrower agrees to pay all reasonable
expenses of the Lender, including, without limitation, the fees and expenses of its counsel, incurred in connection with (i) the
enforcement of any part of this Agreement, and any waiver or amendment of any provision hereof, (ii) the administration of this
Agreement after the occurrence and during the continuance of any Default hereunder, or (iii) the failure by the Borrower to perform
or observe any of the provisions of this Agreement.

 

SECTION 8.     MISCELLANEOUS

 

Section 8.1     Election
of Remedies; Waivers. No single or partial waiver by the Lender of any Default, Event of Default, right or remedy which it
may have shall operate as a waiver of any other Default, Event of Default, right or remedy or of the same Default, Event of Default,
right or remedy on a future occasion. The Borrower hereby waives presentment, notice of dishonor and protest and all other notices
and demands whatsoever, except as specifically provided in this Agreement.

 

    	7

    	 

    

 

Section 8.2     Amendment.
No amendment, modification or waiver of any provision of this Agreement, nor consent to any departure by the Borrower here from,
shall in any event be effective unless the same shall be in writing and signed by the Lender and shall otherwise be made in accordance
with the provisions hereof, and then such amendment, waiver or consent shall be effective only in the specific instance and the
specific purpose for which it is given.

 

Section 8.3     Survival
of Agreements. All agreements, representations and warranties made herein and in any certificates delivered and pursuant hereto
shall survive the execution and delivery of this Agreement and shall continue in full force and effect until the indebtedness of
the Borrower under this Agreement has been paid and satisfied in full.

 

Section 8.4     Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the Borrower and the Lender and their respective
successors and assigns, except that the Borrower may not transfer or assign any of its rights or interests hereunder without the
prior written consent of the Lender.

 

Section 8.5     Notices.
All notices and other communications given to or made upon any party hereto in connection with this Agreement shall be in writing
and shall be deemed to have been given to or made upon the intended party if transmitted by registered mail, facsimile followed
by confirmation of delivery, or by express courier, in each case to the addresses set forth on the first page of this Agreement.

 

Section 8.6     Governing
Law. This Agreement and the rights and obligations of the Borrower and the Lender hereunder shall be governed and construed
and enforced in accordance with the laws of the Grand Duchy of Luxembourg.

 

Section 8.7     Jurisdiction.
The parties agree that the competent commercial courts of Liege, Belgium, shall be the exclusive forum for any dispute arising
out of or in connection with this Agreement or for the enforcement thereof, and hereby submit to the jurisdiction of those courts.

 

Section 8.8     Captions.
The headings of the sections of this Agreement have been inserted solely for convenience of reference and shall not modify, define
or limit the express provisions of this Agreement.

 

    	8

    	 

    

 

Section 8.9     Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which, when taken together,
shall constitute one and the same instrument.

 

The remainder of this
page intentionally left blank

 

    	9

    	 

    

 

IN WITNESS WHEREOF,
the Borrower and the Lender have caused this Agreement to be executed and delivered on their behalf as of the date first written
above.

 

For and on behalf of:

	Nexeon Medsystems Europe, S.à r.l.
	 	 	 
	 	 	 
	Signature:	/s/ Faruk Durusu	 
	Name:	Faruk Durusu	 
	Title:	Class A Manager	 
	 	 	 
	 	 	 
	Signature:	/s/ William Rosellini	 
	Name:	William Rosellini	 
	Title:	Class B Manager	 
	 	 	 

 

 

For and on behalf of:

	Nexeon Medsystems Belgium S.p.rl.,
	 	 	 
	 	 	 
	Signature:	/s/ William Rosellini	 
	Name:	William Rosellini	 
	Title:	CEO	 

 

    	10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]